Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements

被引:6
|
作者
Reddy, Aananya [1 ,2 ]
Reddy, Ruhananhad P. [1 ,2 ]
Roghani, Aryan Kia [1 ,3 ]
Garcia, Ricardo Isaiah [1 ]
Khemka, Sachi [1 ]
Pattoor, Vasanthkumar [1 ,5 ]
Jacob, Michael [1 ,4 ]
Reddy, P. Hemachandra [1 ,6 ,7 ,8 ,9 ]
Sehar, Ujala [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Lubbock High Sch, Lubbock, TX 79401 USA
[3] Frenship High Sch, Lubbock, TX 79382 USA
[4] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA
[5] Univ S Florida, Tampa, FL 33620 USA
[6] Texas Tech Univ, Coll Human Med, Hlth Sci Ctr, Nutr Sci Dept, Lubbock, TX 79430 USA
[7] Texas Tech Univ, Hlth Sci Ctr, Publ Hlth Dept, Grad Sch Biomed Sci, Lubbock, TX 79430 USA
[8] Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, Dept pf Speech Language & Hearing Serv, Lubbock, TX 79430 USA
[9] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA
基金
美国国家卫生研究院;
关键词
Parkinson's disease; Early detectable biomarkers; Therapeutic strategies; Artificial intelligence; Machine learning tools; SOCIOECONOMIC-STATUS; ETHNIC VARIATION; BIOMARKERS; PROGRESSION; POPULATION; PREVALENCE; CONSENT; IMPACT;
D O I
10.1016/j.arr.2024.102410
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disorder, globally affecting men and women at an exponentially growing rate, with currently no cure. Disease progression starts when dopaminergic neurons begin to die. In PD, the loss of neurotransmitter, dopamine is responsible for the overall communication of neural cells throughout the body. Clinical symptoms of PD are slowness of movement, involuntary muscular contractions, speech & writing changes, lessened automatic movement, and chronic tremors in the body. PD occurs in both familial and sporadic forms and modifiable and non-modifiable risk factors and socioeconomic conditions cause PD. Early detectable diagnostics and treatments have been developed in the last several decades. However, we still do not have precise early detectable biomarkers and therapeutic agents/drugs that prevent and/or delay the disease process. Recently, artificial intelligence (AI) science and machine learning tools have been promising in identifying early detectable markers with a greater rate of accuracy compared to past forms of treatment and diagnostic processes. Artificial intelligence refers to the intelligence exhibited by machines or software, distinct from the intelligence observed in humans that is based on neural networks in a form and can be used to diagnose the longevity and disease severity of disease. The term Machine Learning or Neural Networks is a blanket term used to identify an emerging technology that is created to work in the way of a "human brain" using many intertwined neurons to achieve the same level of raw intelligence as that of a brain. These processes have been used for neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, to assess the severity of the patient's condition. In the current article, we discuss the prevalence and incidence of PD, and currently available diagnostic biomarkers and therapeutic strategies. We also highlighted
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Potential Ocular Biomarkers for Early Detection of Alzheimer’s Disease and Their Roles in Artificial Intelligence Studies
    Pareena Chaitanuwong
    Panisa Singhanetr
    Methaphon Chainakul
    Niracha Arjkongharn
    Paisan Ruamviboonsuk
    Andrzej Grzybowski
    Neurology and Therapy, 2023, 12 : 1517 - 1532
  • [32] Explainable Artificial Intelligence (EXAI) Models for Early Prediction of Parkinson's Disease Based on Spiral and Wave Drawings
    Saravanan, S.
    Ramkumar, Kannan
    Narasimhan, K.
    Vairavasundaram, Subramaniyaswamy
    Kotecha, Ketan
    Abraham, Ajith
    IEEE ACCESS, 2023, 11 : 68366 - 68378
  • [33] Unveiling the Diagnostic Potential of Linguistic Markers in Identifying Individuals with Parkinson's Disease through Artificial Intelligence: A Systematic Review
    Palmirotta, Cinzia
    Aresta, Simona
    Battista, Petronilla
    Tagliente, Serena
    Lagravinese, Gianvito
    Mongelli, Davide
    Gelao, Christian
    Fiore, Pietro
    Castiglioni, Isabella
    Minafra, Brigida
    Salvatore, Christian
    BRAIN SCIENCES, 2024, 14 (02)
  • [35] Importance of low diagnostic Accuracy for early Parkinson's disease
    Beach, Thomas G.
    Adler, Charles H.
    MOVEMENT DISORDERS, 2018, 33 (10) : 1551 - 1554
  • [36] Advanced Parkinson's Disease Detection: A comprehensive artificial intelligence approach utilizing clinical assessment and neuroimaging samples
    Islam N.
    Turza M.S.A.
    Fahim S.I.
    Rahman R.M.
    International Journal of Cognitive Computing in Engineering, 2024, 5 : 199 - 220
  • [37] New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson's disease
    Gupta, Rohan
    Kumari, Smita
    Senapati, Anusha
    Ambasta, Rashmi K.
    Kumar, Pravir
    AGEING RESEARCH REVIEWS, 2023, 90
  • [38] Biomarkers for the early detection of Parkinson's and Alzheimer's disease
    Berg, Daniela
    NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) : 133 - 136
  • [39] Early detection of Parkinson's disease: Unmet needs
    Gerlach, Manfred
    Hendrich, Albrecht
    Hueber, Roland
    Jost, Wolfgang
    Winkler, Juergen
    Woitalla, Dirk
    Riederer, Peter
    NEURODEGENERATIVE DISEASES, 2008, 5 (3-4) : 137 - 139
  • [40] Early Detection of Parkinson's disease through Voice
    Vikas
    Sharma, R. K.
    2014 INTERNATIONAL CONFERENCE ON ADVANCES IN ENGINEERING AND TECHNOLOGY (ICAET), 2014,